CYTOCARE® 715 C-Line

Cytocare 715 (C-Line) – The most potent option with 75 mg of hyaluronic acid, this deep hydration treatment plumps the skin, reduces wrinkles, and enhances elasticity, perfect for mature or dehydrated skin in need of maximum rejuvenation.

314.00

 Product information

Active substances

NON CROSSLINKED HYALURONIC ACID, CT50

Manufacturer

Laboratoires Revitacare

Pack size

5 x 5ml/vial

People also bought

ORTHOVISC®
KDA US

ORTHOVISC®

29.00
RESTYLANE® KYSSE with Lidocaine
KDA US

RESTYLANE® KYSSE with Lidocaine

70.00
JALUPRO® SUPER HYDRO

JALUPRO® SUPER HYDRO

55.00
VISCODERM® SKINKÒ E + VISCODERM® SKINKÒ KIT

VISCODERM® SKINKÒ E + VISCODERM® SKINKÒ KIT

243.00
ALIAXIN® SV

ALIAXIN® SV

136.00
RADIESSE® 1.5ml
KDA US

RADIESSE® 1.5ml

96.00

Fast 5–10 Day Delivery

We guarantee your order will arrive quickly. Most parcels are delivered within 5–10 business days, ensuring you get the products you need when you need them.

Dedicated Account Manager

Enjoy personalized support with a dedicated account manager. From product selection to tracking, you’ll always have a trusted partner by your side.

Premium Brands, Ready to Ship

Shop confidently from our selection of medical products. Each item is available for fast, reliable delivery, so your practice stays fully stocked.

100% Authentic Products with Full Traceability

We supply only authentic products, backed by full traceability. Every order comes with confidence, transparency, and assurance of verified sourcing.

Why buy CYTOCARE® 715 C-Line

Why Clinics Choose Cytocare 715 C Line for Skin Revitalization

Cytocare 715 C Line is widely used by medical professionals seeking reliable solutions for improving skin quality in patients with more advanced signs of aging. Its formulation supports deep hydration and revitalization, making it a consistent choice in aesthetic practice.

Clinics that buy Cytocare 715 C Line (5x5ml vials) online often prioritize products that integrate easily into treatment protocols while delivering visible improvements in skin condition over time.

Key Benefits of Cytocare 715 C Line Treatments

Cytocare 715 C Line is designed to address multiple aspects of skin aging through a combination of hydration and bio-revitalization:

  • Supports deep and sustained skin hydration.
  • Improves elasticity and firmness in aging skin.
  • Helps reduce the appearance of fine lines and wrinkles.
  • Enhances overall skin texture and radiance.
  • Contributes to a smoother and more refreshed appearance.

These benefits make it suitable for patients who require more intensive skin support than lighter formulations.

Expected Outcomes After Cytocare 715 C Line Injections

Following treatment, patients typically notice gradual improvements in skin hydration and texture. The skin often appears plumper, with a smoother surface and improved tone.

With continued sessions, the effects become more visible, including enhanced elasticity and reduced visible signs of aging. Results develop progressively, aligning with the regenerative nature of the treatment.

Mechanism of Action and Skin Interaction

Cytocare 715 C Line works by delivering hyaluronic acid along with a complex of revitalizing nutrients directly into the skin. This combination helps restore hydration levels while supporting cellular activity.

The formulation interacts with the dermal environment by improving moisture retention and creating conditions that support healthier skin function over time.

Composition and Active Ingredient Profile

Cytocare 715 C Line contains non-crosslinked hyaluronic acid, which is known for its ability to retain water and support skin hydration. This ingredient plays a key role in maintaining skin volume and elasticity.

It is combined with the CT50 rejuvenating complex, which contains vitamins, amino acids, minerals, and other nutrients that help improve skin quality and promote revitalization.

Cytocare Range and Manufacturer Overview

Cytocare is manufactured by Laboratoires Filorga, France, a company recognized for its focus on aesthetic medicine and injectable skin treatments. As part of a broader range of injectables, Cytocare products are designed to address different stages of skin aging and treatment goals:

  • Cytocare 502: Suitable for younger skin and preventive treatments focused on maintaining hydration and delaying early signs of aging.
  • Cytocare 532: Designed for early aging concerns, helping improve skin quality and elasticity.
  • Cytocare 516: Targets intermediate skin aging, supporting hydration and improving overall skin tone.

Cytocare 715 C Line is positioned as the most intensive option within the range, developed for mature or significantly dehydrated skin. Clinics can explore the full Cytocare product range to select the most appropriate solution for their patients.

Indications and Treatment Areas

Cytocare 715 C Line is used across multiple treatment areas where skin revitalization is required:

  • Face, for improving hydration, texture, and overall appearance.
  • Neck, where signs of aging often appear earlier.
  • Décolleté, to restore smoother and more even skin.
  • Hands, to address dryness and visible aging.

These areas benefit from improved hydration and elasticity, contributing to a more uniform and refreshed look.

Administration Techniques and Clinical Use

Cytocare 715 C Line is applied through intradermal injections, allowing the formulation to be placed directly within the skin. The specific technique and method can differ based on the targeted area and the practitioner’s chosen protocol.

This treatment is intended for professional use only and requires appropriate training. Clinics often use precision tools such as cannulas and needles to ensure accurate, controlled application. It is also commonly integrated into broader mesotherapy treatments.

Product Format and Pack Details

Cytocare 715 C Line is supplied in a format suitable for clinical use and consistent application:

  • 5 x 5 ml sterile vials.
  • Pre-measured formulation ready for injection.
  • Designed for multiple-session treatment protocols.

This packaging allows clinics to manage treatments efficiently while maintaining product integrity.

Safety Considerations and Possible Side Effects

When administered by experienced practitioners, Cytocare 715 C Line is typically well accepted in clinical use. Any reactions that occur are usually mild and stem from the injection itself rather than the product:

  • Redness at the injection site.
  • Swelling that may persist for a short period.
  • Bruising, particularly in sensitive areas.
  • Mild discomfort during or after treatment.
  • Temporary sensitivity or itching.
  • Small injection-site irregularities that resolve as the product distributes.

These reactions are typically short-lived and resolve without intervention. In rare cases, more serious complications such as infection, prolonged inflammation, or hypersensitivity may occur and require medical attention.

Contraindications and Patient Restrictions

Cytocare 715 C Line is not suitable for all patients, and careful screening is required before treatment. The following situations should be considered before proceeding:

  • Known hypersensitivity or allergy to hyaluronic acid or any component of the formulation.
  • Active skin infections, inflammation, or irritation in the treatment area.
  • Autoimmune disorders or conditions affecting wound healing.
  • Patients with a history of severe allergic reactions or anaphylaxis.
  • Pregnancy or breastfeeding, where treatment is generally postponed.
  • Use in areas with compromised skin integrity, including open wounds or recent procedures.
  • Patients prone to keloid formation or abnormal scarring.

A thorough medical history and consultation are essential for determining suitability and minimizing potential risks associated with treatment.

Storage and Handling Recommendations

Proper storage is essential to maintain the effectiveness and safety of Cytocare 715 C Line. The product should be kept at the recommended temperature and protected from excessive heat or freezing.

Vials must remain sealed until use, and sterile handling should be maintained throughout preparation and administration to ensure patient safety.